首页> 美国卫生研究院文献>BMC Cancer >Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lymphoma
【2h】

Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lymphoma

机译:治疗原发性胃弥漫性大B细胞淋巴瘤后胃腺癌的风险增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThere have been sporadic reports about synchronous as well as metachronous gastric adenocarcinoma and primary gastric lymphoma. Many reports have dealt with metachronous gastric adenocarcinoma in mucosa-associated lymphoid tissue lymphoma of stomach. But to our knowledge, there have been no reports that document the increased incidence of metachronous gastric adenocarcinoma in patients with gastric diffuse large B-cell lymphoma. This retrospective study was conducted to estimate the incidence of metachronous gastric adenocarcinoma after primary gastric lymphoma treatment, especially in diffuse large B-cell lymphoma.
机译:背景已有关于同步性和异时性胃腺癌和原发性胃淋巴瘤的零星报道。胃黏膜相关淋巴样组织淋巴瘤中有许多关于异时性胃腺癌的报道。但据我们所知,尚无报道表明胃弥漫性大B细胞淋巴瘤患者异时性胃腺癌的发生率增加。这项回顾性研究旨在评估原发性胃淋巴瘤治疗后异时性胃腺癌的发生率,尤其是在弥漫性大B细胞淋巴瘤中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号